[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NeoGenomics to Present New Research at ASCO Annual Meeting 2026

Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies

NEO : 10.44 (-0.76%)
NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:...

NEO : 10.44 (-0.76%)
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NEO : 10.44 (-0.76%)
CRL : 182.07 (+0.75%)
3 Russell 2000 Stocks We’re Skeptical Of

3 Russell 2000 Stocks We’re Skeptical Of

MCY : 98.62 (+0.60%)
NEO : 10.44 (-0.76%)
AEO : 16.14 (+2.15%)
3 Reasons NEO is Risky and 1 Stock to Buy Instead

3 Reasons NEO is Risky and 1 Stock to Buy Instead

NEO : 10.44 (-0.76%)
5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

NEO : 10.44 (-0.76%)
NEO Q1 Deep Dive: High-Value Test Expansion and Commercial Execution Drive Oncology Growth

NEO Q1 Deep Dive: High-Value Test Expansion and Commercial Execution Drive Oncology Growth

NEO : 10.44 (-0.76%)
NeoGenomics: Q1 Earnings Snapshot

NeoGenomics: Q1 Earnings Snapshot

NEO : 10.44 (-0.76%)
NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue

NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue

NEO : 10.44 (-0.76%)
NeoGenomics Reports First Quarter 2026 Results

First quarter total revenue increased 11% YoY to $187 million; Clinical revenue grew 14%, including NGS growth of 26%; Company announces...

NEO : 10.44 (-0.76%)

Barchart Exclusives

This High-Yield Home Improvement Stock Just Hiked Its Dividend by 4.2%
Lowe’s Companies raised its quarterly dividend by 4.2% to $1.25 per share, marking its 55th consecutive year of increases and reinforcing its status as a Dividend King amid a challenging housing market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.